Monday, March 4, 2019
Lorex Memo
I forget channelize what Information I found Important in making the surmount economic decision for the target take aim count. There were several represent that we need to consider when analyzing what will return the most profit. I will walk you through the data I employ, the analytical method performed, and my testimony on what I believe would be the most profitable for intelligence Pharmaceuticals. Determining the Proportion of Properly Filled Bottles I started by determine a list of target fill sites to test for your follow.There Is a standard blueprint distribution function that washbasin be used to determine the probability for different fill computes. I used the ask fill rate of 10 ounces as a basis of blotto the proportion filled properly for that ounce level. The results only showed a 50% probability as you roll in the hay consume in exhibit A, in the first column. I sum upd the fill rate by . 1 ounces and continued to weigh the probability using the same standard normal function. These results, shown in exhibit A, can be used to help calculate the highest possible region per causa by considering the impact on gross and variable make up.The results show, with every . 1 ounce increase to the target fill rate, the probability that the bottles with meet the proper fill indispensability of 10 ounces goes up. anticipate Revenue per baptistry Now that the probability of properly filled bottles has been calculated, we can determine our expected amount of revenue per case. We know that a case that Is properly filled will sell for $1 86 and a case that has been reworked will sell for 80% of fill rate of jazz. Is $167. 40.We go at this number by assuming 50% of the cases will be sold at $186 and 50% will be sold at 80% of $186, or $148. 80. You can see on Exhibit A, that as the probability of properly filled bottles increases, revenue also increases. This is because the high probability that the cases will meet the 10 ounce requiremen t, the more cases you will be able to sell at full price. Cost of Active Ingredients per Case When trying to maximize profit, it is Copernican to consider what lives be dismissal to impact the bottom crinkle.Specifically, we will want to evaluate the variable costs that change related to the target fill line of work. I started with the data the company provided in the projected operating profit and I calculated what the cost per case of active ingredients per ounce would be. I included the active ingredients and the mix direct labor because these amounts correlate with how many ounces ar in each total. The filling materials, filling direct labor, and filling overhead are important costs that will affect the bottom line however they are not dependent on the target fill rate.By calculating a per ounce amount, we can calculate the active ingredient cost per case. As you can see in Exhibit A, the higher the target rate per bottle, the higher the cost per case. This is because th e more ounces used to fill the bottles the more ingredients are going to be used. Cost of Rework per Case Another cost to consider is the cost of rework per case. Unless every bottle meets the ill requirement of 10 ounces, there is going to be a rework cost. disposed the hourly wage and rate at which a case can be reworked, we can calculate a per case rework amount.The higher probability that the bottles are properly filled implies a lower cost of rework. You can see in exhibit A, the cost of rework decreases as the target fill rate increases. Recommendation/Conclusion Based on the calculations, I would recommend that Lore Pharmaceuticals set a target rate of 10. 4 for the current merchandise line of Linton. As you can see in Exhibit A, the highest contribution per case is at the 10. 4 rate. When we increase the target fill rate to 10. 5, the contribution per case decreases. Even though at a target rate of 10. Returns the highest projected revenue per case, the amount of active in gredients used to fill each bottle increases therefore our contribution per case decreases. An alternative solution could be to invest in a more efficient production line for this drug. The quality of the production line that is being used for Linton is older and much slower than the other production lines in use. We would need to consider whether making improvements to the current production line or buying a completely ewe machine would be expenditure it for Lore verses using the current production line.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.